Fournier’s Gangrene in a Patient on Dapagliflozin Treatment for Type 2 Diabetes

Journal of Diabetes - United States
doi 10.1111/1753-0407.12896
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2014English

Prognostic Factors in Fournier’s Gangrene

Journal of Evolution of Medical and Dental Sciences
2014English

Fatal Fournier’s Gangrene Caused by Clostridium Ramosum in a Patient With Central Diabetes Insipidus and Insulin-Dependent Diabetes Mellitus: A Case Report

BMC Infectious Diseases
Infectious Diseases
2018English

Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Towards Zero Mortality in Fournier’s Gangrene

Central European Journal of Urology
Urology
2013English

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

Cureus
2017English

Severe Fournier’s Gangrene in a Patient With Rectal Cancer: Case Report and Literature Review

World Journal of Surgical Oncology
SurgeryOncology
2016English

A Clinical Study of Fournier’s Gangrene and Use of Honey Dressing in Treatment

International Journal of Research in Medical Sciences
2018English

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy